Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial
新辅助吡咯替尼联合曲妥珠单抗和化疗治疗I-III期HER2阳性乳腺癌:一项II期临床试验
期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13546
Xuhong, Juncheng; Qi, Xiaowei; Tang, Peng; Fan, Linjun; Chen, Li; Zhang, Fan; Tan, Xuanni; Yan, Wenting; Zhong, Ling; He, Cheng; Liang, Yan; Ren, Lin; Wang, Minghao; Zhang, Yi; Jiang, Jun